About Famotidine API
Therapeutic Category Gastro-Intestinal - GI
CAS Number
76824-35-6
API Technology
Synthetic
Dose Form
Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted
Mechanism of Action
Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion. Both the acid concentration and volume of gastric secretion are suppressed by famotidine, while changes in pepsin secretion are proportional to volume output.
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
Rabeprazole Sodium (Form Y)
Gastro-Intestinal - GI
Vonoprazan Fumarate
Gastro-Intestinal - GI
Pantoprazole Sodium
Gastro-Intestinal - GI
Omeprazole Magnesium (Amorphous & Crystalline)
Gastro-Intestinal - GI
Omeprazole Base (Crystalline)
Gastro-Intestinal - GI
Nizatidine
Gastro-Intestinal - GI
Esomeprazole Magnesium Trihydrate
Gastro-Intestinal - GI
Famotidine
Gastro-Intestinal - GI
FAQs
To treat heartburn due to acid indigestion and sour stomach caused by eating or drinking certain foods or drinks.
-
Famotidine belongs to class -III of BCS classification
-
Famotidine have DMFs available for the US and CEP.
-
Store it at room temperature and away from excess heat and moisture.
-
Famotidine is available in 20 mg and 40 mg dosage forms.